Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3 …
SH Kennedy, RW Lam, RS McIntyre… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …
conducted a revision of the 2009 guidelines by updating the evidence and …
Inflammation and the dimensions of depression: a review
Patients with depressive disorders show a wide range of clinical manifestations including
cognitive and neurovegetative symptoms. Importantly, these symptoms can differ in terms of …
cognitive and neurovegetative symptoms. Importantly, these symptoms can differ in terms of …
The clinical characterization of the adult patient with depression aimed at personalization of management
Depression is widely acknowledged to be a heterogeneous entity, and the need to further
characterize the individual patient who has received this diagnosis in order to personalize …
characterize the individual patient who has received this diagnosis in order to personalize …
Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis
Objectives: Evidence suggests that childhood maltreatment may negatively affect not only
the lifetime risk of depression but also clinically relevant measures of depression, such as …
the lifetime risk of depression but also clinically relevant measures of depression, such as …
Machine learning, statistical learning and the future of biological research in psychiatry
Psychiatric research has entered the age of 'Big Data'. Datasets now routinely involve
thousands of heterogeneous variables, including clinical, neuroimaging, genomic …
thousands of heterogeneous variables, including clinical, neuroimaging, genomic …
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline
Objective: Major depressive disorder has been linked with inflammatory processes, but it is
unclear whether individual differences in levels of inflammatory biomarkers could help …
unclear whether individual differences in levels of inflammatory biomarkers could help …
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
O Köhler-Forsberg, HN Buttenschøn, KE Tansey… - Brain, behavior, and …, 2017 - Elsevier
Introduction Population-based studies have associated inflammation, particularly higher C-
reactive protein (CRP), with depressive severity, but clinical trials in major depressive …
reactive protein (CRP), with depressive severity, but clinical trials in major depressive …
Reevaluating the efficacy and predictability of antidepressant treatments: a symptom clustering approach
Importance Depressive severity is typically measured according to total scores on
questionnaires that include a diverse range of symptoms despite convincing evidence that …
questionnaires that include a diverse range of symptoms despite convincing evidence that …
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …
guidelines for treating depressive disorders with antidepressants was undertaken in order to …
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
BackgroundSymptom dimensions have not yet been comprehensively tested as predictors
of the substantial heterogeneity in outcomes of antidepressant treatment in major depressive …
of the substantial heterogeneity in outcomes of antidepressant treatment in major depressive …